Transcriptomic analyses further allowed the authors to identify an adrenergic-to-mesenchymal transition, with neuroblastoma cells lacking ARID1A exhibiting an enriched mesenchymal gene signature [41]. The gene discussed is ARID1A; the disease is neuroblastoma.